Evidence map›Paper›PMID 32847625›Full record

ReviewStem cell research & therapy2020

Controlling stem cell fate using cold atmospheric plasma.

Fei Tan, Yin Fang, Liwei Zhu, Mohamed Al-Rubeai

Open access · goldAbstract readReview
In one paragraph

Review in Stem cell research & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Advances in Regulating Cellular Behavior Using Micropatterns.The Yale journal of biology and medicine · 2023
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Fei TanDepartment of ORL-HNS, Affiliated East Hospital of Tongji University, Shanghai, China. iatrologist@163.com.ORCID 0000-0003-1010-0163
Yin FangSchool of Medicine and Institute for Advanced Study, Tongji University, Shanghai, China.
Liwei ZhuDepartment of ORL-HNS, Affiliated East Hospital of Tongji University, Shanghai, China.
Mohamed Al-RubeaiSchool of Chemical and Bioprocess Engineering, and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
Tongji University · CNShanghai East Hospital · CNUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The stem cell is the foundation of regenerative medicine and tissue engineering. Regulating specific stem cell fate, such as cell attachment, proliferation, differentiation, and even death, undergoes continuous development. Cold atmospheric plasma (CAP), the core technology of plasma medicine, is attracting tremendous attention due to its ability and versatility to manipulate various types of cells, including stem cells. Specifically, the direct and indirect applications of CAP in controlling cell fate are best exemplified by upfront irradiation of the stem cells and modification of the stem cell niche, respectively. This review will describe the recent advances in various CAP strategies, both direct and indirect, and their influence on the fate of healthy and cancer stem cells. Particular emphasis will be placed on the mechanism of connecting the physical and chemical cues carried by the plasma and biological changes presented by the cells, especially at the transcriptomic level. The ultimate goal is to exploit CAP's potential in regenerative medicine.

Indexed as

Plasma GasesCell DifferentiationRegenerative MedicineStem CellsTissue EngineeringPlasma GasesAtmospheric plasmaCell attachmentCell deathCell differentiationCell proliferationCold plasmaExtracellular matrixNon-thermal plasmaPlasma-activated mediumPlasma medicineRegenerative medicineScaffoldStem cellStem cell nicheSurface modificationTissue engineering

Identifiers

PMID32847625
PMCPMC7449033
OpenAlexW3080541794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.